Lucerón-Lucas-Torres Maribel, Ruiz-Grao Marta C, Cavero-Redondo Iván, di Lorenzo Chiara, Pascual-Morena Carlos, Priego-Jiménez Susana, Gómez-Guijarro Dolores, Álvarez-Bueno Celia
Centro de Estudios Socio-Sanitarios, Grupo de investigación Age-ABC Universidad de Castilla-La Mancha; Nursing Faculty, University of Castilla-La Mancha, Albacete, Spain.
Centro de Estudios Socio-Sanitarios, Grupo de investigación Age-ABC Universidad de Castilla-La Mancha; Nursing Faculty, University of Castilla-La Mancha, Albacete, Spain.
J Nutr Health Aging. 2025 Jun;29(6):100539. doi: 10.1016/j.jnha.2025.100539. Epub 2025 Mar 23.
The aim of this study was to analyze the effects of wine consumption on the lipid profile, distinguishing between triglycerides, total cholesterol, LDL, HDL and fibrinogen.
We examined the MEDLINE (via PubMed), Scopus, Cochrane, and Web of Science databases to conduct this systematic review and meta-analysis. PROSPERO has already recorded this study under registration number CRD42023396666.
Thirty-three studies were included in this systematic review, and 29 were included in the meta-analysis. The pooled ES for the effect of red wine consumption on the different lipid profile parameters was significant only for the effect of red wine on the LDL parameter in the prepost studies (-0.29 (95% CI -0.54, -0.05)). The pooled ES for the effect of white wine in prepost studies and clinical trials for the effect of wine consumption on the different parameters did not show any significant results.
This systematic review and meta-analysis revealed that wine consumption has an effect on reducing LDL and has no effect on total cholesterol, HDL, triglycerides, or fibrinogen. This research revealed that the duration of the intervention affects triglyceride and total cholesterol levels, indicating that longer interventions are more effective for these two parameters.
CRD42023396666 (PROSPERO). URL REGISTRATION: https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=396666.
本研究旨在分析饮酒对血脂谱的影响,区分甘油三酯、总胆固醇、低密度脂蛋白、高密度脂蛋白和纤维蛋白原。
我们检索了MEDLINE(通过PubMed)、Scopus、Cochrane和科学网数据库来进行这项系统评价和荟萃分析。PROSPERO已将本研究登记在注册号CRD42023396666下。
本系统评价纳入了33项研究,荟萃分析纳入了29项研究。在前后对照研究中,饮用红酒对不同血脂谱参数影响的合并效应量仅在红酒对低密度脂蛋白参数的影响方面具有统计学意义(-0.29(95%CI -0.54,-0.05))。在前后对照研究和临床试验中,饮用白葡萄酒对不同参数影响的合并效应量未显示出任何显著结果。
本系统评价和荟萃分析表明,饮酒对降低低密度脂蛋白有作用,而对总胆固醇、高密度脂蛋白、甘油三酯或纤维蛋白原无作用。本研究表明,干预持续时间会影响甘油三酯和总胆固醇水平, 这表明较长时间的干预对这两个参数更有效。
CRD42023396666(PROSPERO)。注册网址:https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=396666 。